Botanical species · safety record

Ophiorrhiza mungos

The EFSA Compendium of Botanicals holds 10 constituent measurements for Ophiorrhiza mungos. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Ophiorrhiza mungos L.

10Constituent measurements

0Safety records

7Cited sources

0Licensed products (Canada)

Regulatory presence

No Health Canada licensed natural health product in the snapshot names this species as a medicinal ingredient under this exact binomial. Absence here means absence from this one register under this one name, not absence from trade, and not a safety verdict.

What the records describe

Constituents measured

Plant parts

Preparations

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
Camptothecin	Shoot	Solvent extraction	0.0096 Percent	High Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)	Resolve DOI
Camptothecin	Roots and other underground parts	Solvent extraction	0.0176 Percent	High Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)	Resolve DOI
Camptothecin	Live plants	Solvent extraction	≤ 471.54 Microgram/gram	Gelpermeation, High Performance Thin Layer Chromatography (HPTLC)	Resolve DOI
Camptothecin	Live plants	Solvent extraction	≥ 168.23 Microgram/gram	Gelpermeation, High Performance Thin Layer Chromatography (HPTLC)	Resolve DOI
(+)-pulegone	Roots and other underground parts	Essential oil	2.4 Percent	Unspecified	No resolvable identifier
Camptothecin	Roots and other underground parts	Solvent extraction	188.6 Microgram/gram	Gelpermeation, High Performance Thin Layer Chromatography (HPTLC)	No resolvable identifier
Cardiac glycosides	Seed	Solvent extraction	—	Nuclear Magnetic Resonance (NMR)	No resolvable identifier
Myrcene	Roots and other underground parts	Essential oil	6.15 Percent	Unspecified	No resolvable identifier
Quinoline alkaloids	Leaves	—	—	Unspecified	No resolvable identifier
Steroidal saponins	Roots and other underground parts	Solvent extraction	—	IR and Raman Spectroscopy	No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

Roja, G. Comparative studies on the camptothecin content from Nothapodytes foetida and Ophiorrhiza species . Natural product research, 2006, vol. 20, no. 1, p. 85-88. DOI
Tafur, Susan., Nelson, Janet D., DeLong, Donald C., Svoboda, Gordon H. Antiviral components of Ophiorrhiza mungos. Isolation of camptothecin and 10-methoxycamptothecin. Lloydia, 1976, p. 261-262.
Sahai, A., Dwivedi, S., Saxena, N. Oleandrigenin-3-O-alpha-L rhamnopyranoside from the seeds of Ophiorrhiza mungos (Linn). International Journal of Chemical Sciences, 2012, vol. 10, no. 2, p. 932-936.
Ahuja, M. M., Nigam, Satgur S. Chemical examination of the essential oil from the roots of Ophiorrhiza mungos. Flavour Industry, 1970, p. 721-724.
Rajan, Renjith., Varghese, Sibi Chirakkadamoolayil., Kurup, Rajani., Gopalakrishnan, Roja., Venkataraman, Ramaswamy., Satheeshkumar, Krishnan., Baby, Sabulal. Search for Camptothecin-yielding Ophiorrhiza species from southern Western Ghats in India: A HPTLC-densitometry study . Industrial crops and products, 2013, vol. 43, p. 472-476. DOI
Krishnakumar, G., Rameshkumar, K. B., Srinivas, Priya., Satheeshkumar, K., Krishnan, P. N. Estimation of camptothecin and pharmacological evaluation of Ophiorrhiza prostrata D. Don and Ophiorrhiza mungos L. . Asian pacific journal of tropical biomedicine, 2012, vol. 2, no. Suppl. 2, p. S727-S731.
Sahai, Alok., Dwivedi, Sudhanshu., Saxena, Nidhi. Isolation and study of the steroidal; saponin 24-alpha-ethyl-20-ene-7-hydro-stigmast-8beta:14beta-Di-3-O-beta-D-xylofuranoside. International Journal of Chemical Sciences, 2010, p. 1669-1674.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature